John F. Wesseling

Affiliations: 
Universidad de Navarra, Pamplona, Navarra, Spain 
Area:
Synapses, Short-term Plasticity
Website:
http://www.cima.es/labs-en/cellular-neurobiology/summary/1
Google:
"John Wesseling"
Mean distance: 13.25 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Conde-Dusman MJ, Dey PN, Elía-Zudaire Ó, et al. (2021) Control of protein synthesis and memory by GluN3A-NMDA receptors through inhibition of GIT1/mTORC1 assembly. Elife. 10
Feldmeyer D, Wesseling JF, Sjöström PJ. (2020) Editorial: Methods for Synaptic Interrogation. Frontiers in Synaptic Neuroscience. 12: 23
Wesseling JF. (2019) Considerations for Measuring Activity-Dependence of Recruitment of Synaptic Vesicles to the Readily Releasable Pool. Frontiers in Synaptic Neuroscience. 11: 32
Wesseling JF, Phan S, Bushong EA, et al. (2019) Sparse force-bearing bridges between neighboring synaptic vesicles. Brain Structure & Function
Raja MK, Preobraschenski J, Del Olmo-Cabrera S, et al. (2019) Elevated synaptic vesicle release probability in synaptophysin/gyrin family quadruple knockouts. Elife. 8
Raja MK, Preobraschenski J, Olmo-Cabrera SD, et al. (2019) Author response: Elevated synaptic vesicle release probability in synaptophysin/gyrin family quadruple knockouts Elife
Pérez-Otaño I, Larsen RS, Wesseling JF. (2016) Emerging roles of GluN3-containing NMDA receptors in the CNS. Nature Reviews. Neuroscience
Mahfooz K, Marco S, Martínez-Turrillas R, et al. (2016) GluN3A promotes NMDA spiking by enhancing synaptic transmission in Huntington's disease models. Neurobiology of Disease
Mahfooz K, Singh M, Renden R, et al. (2016) A Well-Defined Readily Releasable Pool with Fixed Capacity for Storing Vesicles at Calyx of Held. Plos Computational Biology. 12: e1004855
Wesseling JF, Pérez-Otaño I. (2015) Modulation of GluN3A expression in Huntington disease: a new n-methyl-D-aspartate receptor-based therapeutic approach? Jama Neurology. 72: 468-73
See more...